Drug Development Immunity Magazine 
Pharma Times
JUNE 18, 2025
The drug is being evaluated as both a monotherapy and in combination with Merck & Co’s Keytruda (pembrolizumab) for cancers such as melanoma, after demonstrating tumour regression, enhanced T-cell infiltration, and durable immune memory in preclinical studies. This field is required.
Pharma Mirror
FEBRUARY 11, 2021
In late 2018, National OncoVenture (NOV), a government-funded virtual oncology drug development program in Korea, approached Samsung Biologics for the development of EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody provided by Eutilex (KOSDAQ:263050). We are extremely glad to.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 8, 2021
All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. Chemotherapy still accounted for 72.6% of the oncology market in China in 2019, compared to 17.1%
Pharmaceutical Technology
JUNE 20, 2025
Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. Can pharma tariffs “Make America Manufacture Again”? Data Insights The gold standard of business intelligence.
pharmaphorum
DECEMBER 23, 2022
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives.
Pharmaceutical Technology
JUNE 18, 2025
Reports Use of Artificial Intelligence in Pharmaceutical Drug Development a. fired 17 sitting members of the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention (CDC), concerns rose about the stance of federal agencies on vaccines. Can pharma tariffs “Make America Manufacture Again”?
pharmaphorum
SEPTEMBER 1, 2020
George Merck on the cover of Time magazine. Thalidomide and the development of drug safety regulation and monitoring. Fordian methods enabled more rational methods of mass production, and increasing understanding of biology and chemistry enabled drug candidates to be chosen systematically rather than discovered serendipitously.
Expert insights. Personalized for you.
81 
Let's personalize your content